Effectiveness and pharmacoeconomic analysis of the treatment of severe asthma with omalizumab in clinical practice.

CONCLUSIONS: The addition of omalizumab to the treatment regime of patients with severe asthma is effective under standard clinical practice, decreases direct and indirect costs, and provides significant  improvements in the health status of patients. PMID: 31072288 [PubMed - in process]
Source: Farmacia Hospitalaria - Category: Drugs & Pharmacology Authors: Tags: Farm Hosp Source Type: research